Glenmark Pharmaceuticals Inc., USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL Single-Dose Vials.
The company acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL Single-Dose Vials from Aspen Pharma USA Inc.
The newly launched product is expected to have the same therapeutic effect as the listed drug product upon which the Agency relied as the basis of safety and effectiveness, Acetadote Injection, 6 gm/30 mL Single-Dose Vials of Cumberland Pharmaceuticals Inc.
The company noted that the Acetadote Injection, 6 gm/30 mL Single-Dose Vials market achieved annual sales of approximately $15.2 million, as per IQVIA sales data for the 12-month period ending January 2025.
For comments and feedback contact: editorial@rttnews.com
Health News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.